Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

MDCT assessment of CAD in type-2 diabetic subjects with diabetic neuropathy: the role of Charcot neuro-arthropathy.

Marano R, Pitocco D, Di Stasio E, Savino G, Merlino B, Trani C, Pirro F, Rutigliano C, Santangelo C, Minoiu AC, Natale L, Bonomo L.

Eur Radiol. 2016 Mar;26(3):788-96. doi: 10.1007/s00330-015-3864-3. Epub 2015 Jul 3.

PMID:
26139314
2.

Comprehensive CT cardiothoracic imaging: a new challenge for chest imaging.

Marano R, Pirro F, Silvestri V, Merlino B, Savino G, Rutigliano C, Meduri A, Natale L, Bonomo L.

Chest. 2015 Feb;147(2):538-551. doi: 10.1378/chest.14-1403. Review.

PMID:
25644907
3.

Emerin increase in regenerating muscle fibers.

Squarzoni S, Sabatelli P, Capanni C, Lattanzi G, Rutigliano C, Columbaro M, Mattioli E, Rocca M, Maraldi NM.

Eur J Histochem. 2005 Oct-Dec;49(4):355-62.

PMID:
16377577
4.

Immunocytochemistry of nuclear domains and Emery-Dreifuss muscular dystrophy pathophysiology.

Maraldi NM, Lattanzi G, Sabatelli P, Ognibene A, Columbaro M, Capanni C, Rutigliano C, Mattioli E, Squarzoni S.

Eur J Histochem. 2003;47(1):3-16. Review.

PMID:
12685553
5.

Inhibition of HIV-1 LTR-driven in vitro transcription by molecular hybrids based on peptide nucleic acids mimicking the NF-kappaB binding site.

Mischiati C, Borgatti M, Feriotto G, Rutigliano C, Breda L, Bianchi N, Gambari R.

Int J Mol Med. 2002 Jun;9(6):633-9.

PMID:
12011981
6.

Staurosporine treatment and serum starvation promote the cleavage of emerin in cultured mouse myoblasts: involvement of a caspase-dependent mechanism.

Columbaro M, Mattioli E, Lattanzi G, Rutigliano C, Ognibene A, Maraldi NM, Squarzoni S.

FEBS Lett. 2001 Dec 14;509(3):423-9.

7.

[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1.

Baraldi PG, Cacciari B, Guiotto A, Romagnoli R, Spalluto G, Leoni A, Bianchi N, Feriotto G, Rutigliano C, Mischiati C, Gambari R.

Nucleosides Nucleotides Nucleic Acids. 2000 Aug;19(8):1219-29.

PMID:
11097052
8.

Pyrazolo-triazoles as light activable DNA cleaving agents.

Manfredini S, Vicentini CB, Manfrini M, Bianchi N, Rutigliano C, Mischiati C, Gambari R.

Bioorg Med Chem. 2000 Sep;8(9):2343-6.

PMID:
11026546
9.

Biospecific interaction analysis (BIA) of low-molecular weight DNA-binding drugs.

Gambari R, Feriotto G, Rutigliano C, Bianchi N, Mischiati C.

J Pharmacol Exp Ther. 2000 Jul;294(1):370-7.

PMID:
10871335
10.

Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1, 4]benzodiazepine and minor-groove-binding oligopyrrole carriers.

Baraldi PG, Balboni G, Cacciari B, Guiotto A, Manfredini S, Romagnoli R, Spalluto G, Thurston DE, Howard PW, Bianchi N, Rutigliano C, Mischiati C, Gambari R.

J Med Chem. 1999 Dec 16;42(25):5131-41.

PMID:
10602698
11.

Interaction of the human NF-kappaB p52 transcription factor with DNA-PNA hybrids mimicking the NF-kappaB binding sites of the human immunodeficiency virus type 1 promoter.

Mischiati C, Borgatti M, Bianchi N, Rutigliano C, Tomassetti M, Feriotto G, Gambari R.

J Biol Chem. 1999 Nov 12;274(46):33114-22.

12.

Analysis of the human HLA-DRA gene upstream region: evidence for a stem-loop array directed by nuclear factors.

Mischiati C, Feriotto G, Bianchi N, Rutigliano C, Giacomini P, Gambari R.

Biochimie. 1999 Mar;81(3):219-28.

PMID:
10385003
13.

PNU 157977: a new potent antitumour agent exhibiting low in vivo toxicity in mice injected with L1210 leukaemia cells.

Baraldi PG, Balboni G, Romagnoli R, Spalluto G, Cozzi P, Geroni C, Mongelli N, Rutigliano C, Bianchi N, Gambari R.

Anticancer Drug Des. 1999 Feb;14(1):71-6.

PMID:
10363029
14.

The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells.

Bianchi N, Osti F, Rutigliano C, Corradini FG, Borsetti E, Tomassetti M, Mischiati C, Feriotto G, Gambari R.

Br J Haematol. 1999 Feb;104(2):258-65.

PMID:
10050705
16.

Biosensor technology and surface plasmon resonance for real-time detection of HIV-1 genomic sequences amplified by polymerase chain reaction.

Bianchi N, Rutigliano C, Tomassetti M, Feriotto G, Zorzato F, Gambari R.

Clin Diagn Virol. 1997 Nov;8(3):199-208.

PMID:
9406650
17.

Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1-DNA interactions and in vitro transcription.

Bianchi N, Rutigliano C, Passadore M, Tomassetti M, Pippo L, Mischiati C, Feriotto G, Gambari R.

Biochem J. 1997 Sep 15;326 ( Pt 3):919-27.

18.

Surface plasmon resonance for real-time detection of molecular interactions between chromomycin and target DNA sequences.

Gambari R, Bianchi N, Rutigliano C, Borsetti E, Tomassetti M, Feriotto G, Zorzato F.

Int J Oncol. 1997 Jul;11(1):145-9.

PMID:
21528193
19.

In vitro and in vivo binding of a CC-1065 analogue to human gene sequences: a polymerase-chain reaction study.

Passadore M, Bianchi N, Feriotto G, Mischiati C, Rutigliano C, Gambari R.

Eur J Pharmacol. 1997 Jan 29;319(2-3):317-25.

PMID:
9042607
20.

Targeting of the Sp1 binding sites of HIV-1 long terminal repeat with chromomycin. Disruption of nuclear factor.DNA complexes and inhibition of in vitro transcription.

Bianchi N, Passadore M, Rutigliano C, Feriotto G, Mischiati C, Gambari R.

Biochem Pharmacol. 1996 Nov 22;52(10):1489-98.

PMID:
8937462
21.

Sequencing of an upstream region of the human HLA-DRA gene containing X' and Y' boxes.

Feriotto G, Mischiati C, Bianchi N, Rutigliano C, Giacomini P, Gambari R.

Nucleic Acids Res. 1995 May 25;23(10):1671-8.

Supplemental Content

Loading ...
Support Center